According to a research report released on Wednesday morning by StockNews.com, the stock rating of British American Tobacco (NYSE: BTI) has been upgraded from neutral to buy.
Other analysts have also released reports on the stock, with Morgan Stanley initiating coverage of British American Tobacco in a report released on Wednesday, November 1st. They have assigned a rating of "Overweight" to the company.
Argus downgraded its rating on British American Tobacco shares from "buy" to "hold," according to a report released on Friday, September 1st.
Citigroup has recently initiated coverage of British-American Tobacco (BAT) with a buy rating, according to a report released on Monday, September 25. This rating differs from the hold rating provided by the other two research analysts, as three additional analysts have recommended a buy rating. According to data from MarketBeat.com, the consensus rating for the company is moderate buy.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
